Rémy Collomp

421 total citations
27 papers, 310 citations indexed

About

Rémy Collomp is a scholar working on Geriatrics and Gerontology, General Health Professions and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Rémy Collomp has authored 27 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Geriatrics and Gerontology, 5 papers in General Health Professions and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Rémy Collomp's work include Pharmaceutical Practices and Patient Outcomes (7 papers), Health, Medicine and Society (4 papers) and Cardiac, Anesthesia and Surgical Outcomes (4 papers). Rémy Collomp is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (7 papers), Health, Medicine and Society (4 papers) and Cardiac, Anesthesia and Surgical Outcomes (4 papers). Rémy Collomp collaborates with scholars based in France, Monaco and Chile. Rémy Collomp's co-authors include Antoine Mangin, Pierre Sicard, Olivia Lesne, Katia Collomp, Charles Talbot, Françoise Lasne, Corinne Buisson, Stéphane Honoré, R. Varin and Christelle Mouchoux and has published in prestigious journals such as Atmospheric Environment, The Journal of Steroid Biochemistry and Molecular Biology and Hormone and Metabolic Research.

In The Last Decade

Rémy Collomp

24 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rémy Collomp France 8 151 86 50 28 24 27 310
Nienke M. Vink Netherlands 5 138 0.9× 37 0.4× 18 0.4× 12 0.4× 16 0.7× 6 400
Chen Wu China 10 83 0.5× 15 0.2× 41 0.8× 14 0.5× 8 0.3× 34 344
Falko Tesch Germany 12 183 1.2× 37 0.4× 14 0.3× 18 0.6× 5 0.2× 32 595
Nagma Zafar United States 6 238 1.6× 82 1.0× 5 0.1× 34 1.2× 11 0.5× 9 450
Tzu‐Ling Chen Taiwan 16 85 0.6× 59 0.7× 12 0.2× 53 1.9× 14 0.6× 34 485
Qingyang Zhu China 12 339 2.2× 67 0.8× 44 0.9× 42 1.5× 9 0.4× 22 547
Yichao Wang Australia 12 153 1.0× 99 1.2× 53 1.1× 38 1.4× 31 1.3× 32 639
Su‐Lun Hwang Taiwan 12 196 1.3× 67 0.8× 30 0.6× 26 0.9× 25 1.0× 23 381
Dankang Li China 14 242 1.6× 39 0.5× 6 0.1× 17 0.6× 39 1.6× 54 620
Ali Asghar Akhlaghi Iran 8 113 0.7× 39 0.5× 18 0.4× 20 0.7× 7 0.3× 13 317

Countries citing papers authored by Rémy Collomp

Since Specialization
Citations

This map shows the geographic impact of Rémy Collomp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rémy Collomp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rémy Collomp more than expected).

Fields of papers citing papers by Rémy Collomp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rémy Collomp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rémy Collomp. The network helps show where Rémy Collomp may publish in the future.

Co-authorship network of co-authors of Rémy Collomp

This figure shows the co-authorship network connecting the top 25 collaborators of Rémy Collomp. A scholar is included among the top collaborators of Rémy Collomp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rémy Collomp. Rémy Collomp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chapuis, Claire, Rémy Collomp, Stéphane Honoré, et al.. (2022). Redistribution of critical drugs in shortage during the first wave of COVID-19 in France: from operating theaters to intensive care units. Journal of Pharmaceutical Policy and Practice. 15(1). 28–28. 6 indexed citations
2.
Corréard, Florian, et al.. (2021). Retour d’expérience de télésanté à l’officine : réflexions pour l’amélioration et l’adaptation des pratiques professionnelles pharmaceutiques. Le Pharmacien Hospitalier et Clinicien. 56(4). 396–404. 2 indexed citations
3.
Juste, M., Christelle Mouchoux, Rémy Collomp, et al.. (2019). De la dispensation au plan pharmaceutique personnalisé : vers un modèle intégratif de pharmacie clinique. Le Pharmacien Hospitalier et Clinicien. 54(1). 56–63. 14 indexed citations
4.
Leguelinel-Blache, Géraldine, Christel Castelli, Clarisse Roux‐Marson, et al.. (2018). Impact of collaborative pharmaceutical care on in-patients’ medication safety: study protocol for a stepped wedge cluster randomized trial (MEDREV study). Trials. 19(1). 19–19. 13 indexed citations
5.
Lieutier, F., et al.. (2018). Politique institutionnelle de bon usage des antibiotiques : ne pas oublier les anciennes molécules ! Exemple des fluoroquinolones. Médecine et Maladies Infectieuses. 48(4). S61–S61. 1 indexed citations
6.
Saint‐Paul, Marie‐Christine, Jean Dellamonica, Johan Courjon, et al.. (2017). Severe intestinal obstruction due to Strongyloides stercoralis in a pregnant woman. Médecine et Maladies Infectieuses. 47(6). 429–431. 10 indexed citations
7.
Piriou, Vincent, et al.. (2017). Prévention des erreurs médicamenteuses en anesthésie et en réanimation (texte court). Anesthésie & Réanimation. 3(1). 108–114. 1 indexed citations
8.
Piriou, Vincent, et al.. (2017). Preventing medication errors in anesthesia and critical care (abbreviated version). Anaesthesia Critical Care & Pain Medicine. 36(4). 253–258. 12 indexed citations
9.
10.
Collomp, Katia, Corinne Buisson, Françoise Lasne, & Rémy Collomp. (2014). DHEA, physical exercise and doping. The Journal of Steroid Biochemistry and Molecular Biology. 145. 206–212. 28 indexed citations
11.
Collomp, Rémy, Fabrice Prieur, François Cottin, et al.. (2013). Therapeutic glucocorticoid administration alters the diurnal pattern of dehydroepiandrosterone. Endocrine. 46(3). 668–671. 7 indexed citations
12.
13.
Absi, Nabil, et al.. (2011). Les RFID pour la production de chimiothérapies : Approches d'ordonnancement avec gestion des compétences. HAL (Le Centre pour la Communication Scientifique Directe). 1 indexed citations
14.
Sicard, Pierre, et al.. (2011). Air quality trends and potential health effects – Development of an aggregate risk index. Atmospheric Environment. 45(5). 1145–1153. 110 indexed citations
15.
Staccini, Pascal, Michel Joubert, Rémy Collomp, Jean‐François Quaranta, & Marius Fieschi. (2007). From the description of activities to the identification of risks for clinical management: a proposal of building, merging and sharing knowledge representations of care processes.. PubMed. 129(Pt 1). 280–4. 1 indexed citations
16.
Collomp, Rémy, et al.. (2007). Proposition de modélisation de la performance par le biais du management des risques : application au circuit du medicament. Logistique & Management. 15(1). 75–83. 1 indexed citations
17.
Collomp, Rémy, et al.. (2005). Le dispositif médical d’annonce. Douleurs Évaluation - Diagnostic - Traitement. 6(4). 197–224. 3 indexed citations
18.
Collomp, Rémy, et al.. (2005). Erythropoietin and neuroprotection: a therapeutic perspective. Journal of Oncology Pharmacy Practice. 11(4). 145–149. 23 indexed citations
19.
Collomp, Rémy, et al.. (2003). [Hypertension and stress].. PubMed. 28(1). 4–8. 6 indexed citations
20.
Ouzan, Denis, et al.. (2000). Que devient le matériel usagé (aiguilles, flacons, seringues, stylos) après injection d'interféron à domicile?. Gastroentérologie Clinique et Biologique. 24(10). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nienke M. Vink Breakdown of academic impact, for papers by Chen Wu Breakdown of academic impact, for papers by Falko Tesch Breakdown of academic impact, for papers by Nagma Zafar Breakdown of academic impact, for papers by Tzu‐Ling Chen Breakdown of academic impact, for papers by Qingyang Zhu Breakdown of academic impact, for papers by Yichao Wang Breakdown of academic impact, for papers by Su‐Lun Hwang Breakdown of academic impact, for papers by Dankang Li Breakdown of academic impact, for papers by Ali Asghar Akhlaghi
Rankless by CCL
2026